IJR vs XLV
iShares Core S&P Small-Cap ETF vs Health Care Select Sector SPDR Fund
- • IJR has the lower expense ratio at 0.06% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | IJR | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.22% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $105.58B | $49.10B |
YTD return | 18.90% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.07 | 0.41 |
P/E ratio | 17.17 | 30.63 |
Last price | $142.33 | $187.94 |
Inception | — | — |
Issuer | iShares | State Street |
IJR top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 1.19% |
| GKOS | Glaukos Corp | 0.80% |
| VSAT | Viasat Inc | 0.60% |
| PAYC | Paycom Software Inc | 0.58% |
| SM | SM Energy Co | 0.55% |
| MTCH | Match Group Inc Ordinary Shares - New | 0.54% |
| PTGX | Protagonist Therapeutics Inc | 0.53% |
| RHP | Ryman Hospitality Properties Inc | 0.52% |
| TGTX | TG Therapeutics Inc | 0.49% |
| LTH | Life Time Group Holdings Inc | 0.49% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About IJR
IJR (iShares Core S&P Small-Cap ETF) is Tracks the S&P SmallCap 600 index. Managed by iShares, the fund carries $105.6B in assets under management, an expense ratio of 0.06%, a dividend yield of 1.22%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 1.2% of the portfolio. Real Estate is the fund's largest sector exposure at 7.4%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.